Croda Promoting PureMax Purification

EDISON, N.J.—Croda Health Care USA is highlighting the competitive advantages of its branded PureMax purification technology, used to produce its Incromega omega-3 concentrates. The proprietary technology removes heavy metals, environmental pollutants and oxidative impurities, while also selectively concentrating eicosapentaenoic acid (EPA) and/or docosahexaenoic acid (DHA). Croda offers a range of Crossential GLA (gamma linolenic acid) concentrates, Procol hydrolyzed type-1 collagens, and Incromega E7010 SR, a 70-percent minimum EPA concentrate.

For more information, visit www.crodausa.com or Booth #3040-3042 at SupplySide West.